Last reviewed · How we verify

NCT06009068

Reliability and Validity of the Surgimap Software for Measuring Quadriceps Angle in Healthy Subjects

Completed Last updated 20 February 2024
What this trial tests

trial testing Surgimap soft ware in Reliability and Validity in 20 participants. Completed in 30 January 2024.

Timeline
30 August 2023
Primary endpoint
30 January 2024
30 January 2024

Quick facts

Lead sponsorCairo University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment20
Start date30 August 2023
Primary completion30 January 2024
Estimated completion30 January 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 25, any sex, with Reliability and Validity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the intra- and inter-rater reliability and concurrent validity of surgimap software for measuring the Q angle Surgimap (Nemaris Inc, New York, NY, USA) is a dedicated spine measurement and surgical planning software which is used in both the research works and the clinical rehabilitation. Q angle is considered to be an index of the vector for action of the patellar tendon and extensors mechanism which is highly affects the patellofemoral joint dysfunction and foot mechanics.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Reliability and Validity

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06009068.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing